Camilla Therese Bruun

Camilla Therese Bruun is an accomplished professional in the biotech and MedTech industries, currently serving as a Business Development Manager at Norlase since July 2021, while also acting as a Strategic Advisor at NoviPel and a Specialist at Third Bridge Group Limited. Camilla's previous roles include Venture Manager at CVX Ventures, Business Development Manager at POLYPEPTIDE THERAPEUTIC SOLUTIONS, and Business Consultant at COLUMBUS VENTURE PARTNERS. With a solid foundation in scientific leadership as the Chief Scientific Officer and co-founder of AlliApp, Camilla has expertise in allergies and immunology. Educational qualifications include a Bachelor's degree in Biochemistry from Københavns Universitet and additional studies at Copenhagen Business School.